Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration

Antonio J Vallejo-Vaz; Asif Akram; Sreenivasa Rao Kondapally Seshasai; Della Cole; Gerald F Watts; G Kees Hovingh; John J P Kastelein; Pedro Mata; Frederick J Raal; Raul D Santos; Handrean Soran; Tomas Freiberger; Marianne Abifadel; Carlos A Aguilar-Salinas; Fahad Alnouri; Rodrigo Alonso; Khalid Al-Rasadi; Maciej Banach; Martin P Bogsrud; Mafalda Bourbon; Eric Bruckert; Josip Car; Richard Ceska; Pablo Corral; Olivier Descamps; Hans Dieplinger; Can T Do; Ronen Durst; Marat V Ezhov; Zlatko Fras; Dan Gaita; Isabel M Gaspar; Jaques Genest; Mariko Harada-Shiba; Lixin Jiang; Meral Kayikcioglu; Carolyn S P Lam; Gustavs Latkovskis; Ulrich Laufs; Evangelos Liberopoulos; Jie Lin; Nan Lin; Vincent Maher; Nelson Majano; A David Marais; Winfried März; Erkin Mirrakhimov; André R Miserez; Olena Mitchenko; Børge G Nordestgaard; EAS Familial Hypercholesterolaemia Studies Collaboration

doi:10.1016/j.atherosclerosissup.2016.10.001

Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration

Antonio J Vallejo-Vaz, Asif Akram, Sreenivasa Rao Kondapally Seshasai, Della Cole, Gerald F Watts, G Kees Hovingh, John J P Kastelein, Pedro Mata, Frederick J Raal, Raul D Santos, Handrean Soran, Tomas Freiberger, Marianne Abifadel, Carlos A Aguilar-Salinas, Fahad Alnouri, Rodrigo Alonso, Khalid Al-Rasadi, Maciej Banach, Martin P Bogsrud, Mafalda BourbonEric Bruckert, Josip Car, Richard Ceska, Pablo Corral, Olivier Descamps, Hans Dieplinger, Can T Do, Ronen Durst, Marat V Ezhov, Zlatko Fras, Dan Gaita, Isabel M Gaspar, Jaques Genest, Mariko Harada-Shiba, Lixin Jiang, Meral Kayikcioglu, Carolyn S P Lam, Gustavs Latkovskis, Ulrich Laufs, Evangelos Liberopoulos, Jie Lin, Nan Lin, Vincent Maher, Nelson Majano, A David Marais, Winfried März, Erkin Mirrakhimov, André R Miserez, Olena Mitchenko, Børge G Nordestgaard, EAS Familial Hypercholesterolaemia Studies Collaboration

Department of Clinical Medicine

64 Citations (Scopus)

Abstract

BACKGROUND: The potential for global collaborations to better inform public health policy regarding major non-communicable diseases has been successfully demonstrated by several large-scale international consortia. However, the true public health impact of familial hypercholesterolaemia (FH), a common genetic disorder associated with premature cardiovascular disease, is yet to be reliably ascertained using similar approaches. The European Atherosclerosis Society FH Studies Collaboration (EAS FHSC) is a new initiative of international stakeholders which will help establish a global FH registry to generate large-scale, robust data on the burden of FH worldwide.

METHODS: The EAS FHSC will maximise the potential exploitation of currently available and future FH data (retrospective and prospective) by bringing together regional/national/international data sources with access to individuals with a clinical and/or genetic diagnosis of heterozygous or homozygous FH. A novel bespoke electronic platform and FH Data Warehouse will be developed to allow secure data sharing, validation, cleaning, pooling, harmonisation and analysis irrespective of the source or format. Standard statistical procedures will allow us to investigate cross-sectional associations, patterns of real-world practice, trends over time, and analyse risk and outcomes (e.g. cardiovascular outcomes, all-cause death), accounting for potential confounders and subgroup effects.

CONCLUSIONS: The EAS FHSC represents an excellent opportunity to integrate individual efforts across the world to tackle the global burden of FH. The information garnered from the registry will help reduce gaps in knowledge, inform best practices, assist in clinical trials design, support clinical guidelines and policies development, and ultimately improve the care of FH patients.

Original language	English
Journal	Atherosclerosis. Supplement
Volume	22
Pages (from-to)	1-32
Number of pages	32
ISSN	1567-5688
DOIs	https://doi.org/10.1016/j.atherosclerosissup.2016.10.001
Publication status	Published - 1 Dec 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.atherosclerosissup.2016.10.001Licence: CC BY-NC-ND

Fingerprint

Dive into the research topics of 'Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration'. Together they form a unique fingerprint.

Cite this

Vallejo-Vaz, A. J., Akram, A., Kondapally Seshasai, S. R., Cole, D., Watts, G. F., Hovingh, G. K., Kastelein, J. J. P., Mata, P., Raal, F. J., Santos, R. D., Soran, H., Freiberger, T., Abifadel, M., Aguilar-Salinas, C. A., Alnouri, F., Alonso, R., Al-Rasadi, K., Banach, M., Bogsrud, M. P., ... EAS Familial Hypercholesterolaemia Studies Collaboration (2016). Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration. Atherosclerosis. Supplement, 22, 1-32. https://doi.org/10.1016/j.atherosclerosissup.2016.10.001

Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes : Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration. / Vallejo-Vaz, Antonio J; Akram, Asif; Kondapally Seshasai, Sreenivasa Rao et al.

In: Atherosclerosis. Supplement, Vol. 22, 01.12.2016, p. 1-32.

Research output: Contribution to journal › Journal article › Research › peer-review

Vallejo-Vaz, AJ, Akram, A, Kondapally Seshasai, SR, Cole, D, Watts, GF, Hovingh, GK, Kastelein, JJP, Mata, P, Raal, FJ, Santos, RD, Soran, H, Freiberger, T, Abifadel, M, Aguilar-Salinas, CA, Alnouri, F, Alonso, R, Al-Rasadi, K, Banach, M, Bogsrud, MP, Bourbon, M, Bruckert, E, Car, J, Ceska, R, Corral, P, Descamps, O, Dieplinger, H, Do, CT, Durst, R, Ezhov, MV, Fras, Z, Gaita, D, Gaspar, IM, Genest, J, Harada-Shiba, M, Jiang, L, Kayikcioglu, M, Lam, CSP, Latkovskis, G, Laufs, U, Liberopoulos, E, Lin, J, Lin, N, Maher, V, Majano, N, Marais, AD, März, W, Mirrakhimov, E, Miserez, AR, Mitchenko, O, Nordestgaard, BG & EAS Familial Hypercholesterolaemia Studies Collaboration 2016, 'Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration', Atherosclerosis. Supplement, vol. 22, pp. 1-32. https://doi.org/10.1016/j.atherosclerosissup.2016.10.001

Vallejo-Vaz AJ, Akram A, Kondapally Seshasai SR, Cole D, Watts GF, Hovingh GK et al. Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration. Atherosclerosis. Supplement. 2016 Dec 1;22:1-32. doi: 10.1016/j.atherosclerosissup.2016.10.001

Vallejo-Vaz, Antonio J ; Akram, Asif ; Kondapally Seshasai, Sreenivasa Rao et al. / Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes : Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration. In: Atherosclerosis. Supplement. 2016 ; Vol. 22. pp. 1-32.

@article{2d15452c3b0a494bb8e2adee33bf68ab,

title = "Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration",

abstract = "BACKGROUND: The potential for global collaborations to better inform public health policy regarding major non-communicable diseases has been successfully demonstrated by several large-scale international consortia. However, the true public health impact of familial hypercholesterolaemia (FH), a common genetic disorder associated with premature cardiovascular disease, is yet to be reliably ascertained using similar approaches. The European Atherosclerosis Society FH Studies Collaboration (EAS FHSC) is a new initiative of international stakeholders which will help establish a global FH registry to generate large-scale, robust data on the burden of FH worldwide.METHODS: The EAS FHSC will maximise the potential exploitation of currently available and future FH data (retrospective and prospective) by bringing together regional/national/international data sources with access to individuals with a clinical and/or genetic diagnosis of heterozygous or homozygous FH. A novel bespoke electronic platform and FH Data Warehouse will be developed to allow secure data sharing, validation, cleaning, pooling, harmonisation and analysis irrespective of the source or format. Standard statistical procedures will allow us to investigate cross-sectional associations, patterns of real-world practice, trends over time, and analyse risk and outcomes (e.g. cardiovascular outcomes, all-cause death), accounting for potential confounders and subgroup effects.CONCLUSIONS: The EAS FHSC represents an excellent opportunity to integrate individual efforts across the world to tackle the global burden of FH. The information garnered from the registry will help reduce gaps in knowledge, inform best practices, assist in clinical trials design, support clinical guidelines and policies development, and ultimately improve the care of FH patients.",

author = "Vallejo-Vaz, {Antonio J} and Asif Akram and {Kondapally Seshasai}, {Sreenivasa Rao} and Della Cole and Watts, {Gerald F} and Hovingh, {G Kees} and Kastelein, {John J P} and Pedro Mata and Raal, {Frederick J} and Santos, {Raul D} and Handrean Soran and Tomas Freiberger and Marianne Abifadel and Aguilar-Salinas, {Carlos A} and Fahad Alnouri and Rodrigo Alonso and Khalid Al-Rasadi and Maciej Banach and Bogsrud, {Martin P} and Mafalda Bourbon and Eric Bruckert and Josip Car and Richard Ceska and Pablo Corral and Olivier Descamps and Hans Dieplinger and Do, {Can T} and Ronen Durst and Ezhov, {Marat V} and Zlatko Fras and Dan Gaita and Gaspar, {Isabel M} and Jaques Genest and Mariko Harada-Shiba and Lixin Jiang and Meral Kayikcioglu and Lam, {Carolyn S P} and Gustavs Latkovskis and Ulrich Laufs and Evangelos Liberopoulos and Jie Lin and Nan Lin and Vincent Maher and Nelson Majano and Marais, {A David} and Winfried M{\"a}rz and Erkin Mirrakhimov and Miserez, {Andr{\'e} R} and Olena Mitchenko and Nordestgaard, {B{\o}rge G} and {EAS Familial Hypercholesterolaemia Studies Collaboration}",

year = "2016",

month = dec,

day = "1",

doi = "10.1016/j.atherosclerosissup.2016.10.001",

language = "English",

volume = "22",

pages = "1--32",

journal = "Journal of atherosclerosis research",

issn = "1567-5688",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes

T2 - Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration

AU - Vallejo-Vaz, Antonio J

AU - Akram, Asif

AU - Kondapally Seshasai, Sreenivasa Rao

AU - Cole, Della

AU - Watts, Gerald F

AU - Hovingh, G Kees

AU - Kastelein, John J P

AU - Mata, Pedro

AU - Raal, Frederick J

AU - Santos, Raul D

AU - Soran, Handrean

AU - Freiberger, Tomas

AU - Abifadel, Marianne

AU - Aguilar-Salinas, Carlos A

AU - Alnouri, Fahad

AU - Alonso, Rodrigo

AU - Al-Rasadi, Khalid

AU - Banach, Maciej

AU - Bogsrud, Martin P

AU - Bourbon, Mafalda

AU - Bruckert, Eric

AU - Car, Josip

AU - Ceska, Richard

AU - Corral, Pablo

AU - Descamps, Olivier

AU - Dieplinger, Hans

AU - Do, Can T

AU - Durst, Ronen

AU - Ezhov, Marat V

AU - Fras, Zlatko

AU - Gaita, Dan

AU - Gaspar, Isabel M

AU - Genest, Jaques

AU - Harada-Shiba, Mariko

AU - Jiang, Lixin

AU - Kayikcioglu, Meral

AU - Lam, Carolyn S P

AU - Latkovskis, Gustavs

AU - Laufs, Ulrich

AU - Liberopoulos, Evangelos

AU - Lin, Jie

AU - Lin, Nan

AU - Maher, Vincent

AU - Majano, Nelson

AU - Marais, A David

AU - März, Winfried

AU - Mirrakhimov, Erkin

AU - Miserez, André R

AU - Mitchenko, Olena

AU - Nordestgaard, Børge G

AU - EAS Familial Hypercholesterolaemia Studies Collaboration

PY - 2016/12/1

Y1 - 2016/12/1

N2 - BACKGROUND: The potential for global collaborations to better inform public health policy regarding major non-communicable diseases has been successfully demonstrated by several large-scale international consortia. However, the true public health impact of familial hypercholesterolaemia (FH), a common genetic disorder associated with premature cardiovascular disease, is yet to be reliably ascertained using similar approaches. The European Atherosclerosis Society FH Studies Collaboration (EAS FHSC) is a new initiative of international stakeholders which will help establish a global FH registry to generate large-scale, robust data on the burden of FH worldwide.METHODS: The EAS FHSC will maximise the potential exploitation of currently available and future FH data (retrospective and prospective) by bringing together regional/national/international data sources with access to individuals with a clinical and/or genetic diagnosis of heterozygous or homozygous FH. A novel bespoke electronic platform and FH Data Warehouse will be developed to allow secure data sharing, validation, cleaning, pooling, harmonisation and analysis irrespective of the source or format. Standard statistical procedures will allow us to investigate cross-sectional associations, patterns of real-world practice, trends over time, and analyse risk and outcomes (e.g. cardiovascular outcomes, all-cause death), accounting for potential confounders and subgroup effects.CONCLUSIONS: The EAS FHSC represents an excellent opportunity to integrate individual efforts across the world to tackle the global burden of FH. The information garnered from the registry will help reduce gaps in knowledge, inform best practices, assist in clinical trials design, support clinical guidelines and policies development, and ultimately improve the care of FH patients.

AB - BACKGROUND: The potential for global collaborations to better inform public health policy regarding major non-communicable diseases has been successfully demonstrated by several large-scale international consortia. However, the true public health impact of familial hypercholesterolaemia (FH), a common genetic disorder associated with premature cardiovascular disease, is yet to be reliably ascertained using similar approaches. The European Atherosclerosis Society FH Studies Collaboration (EAS FHSC) is a new initiative of international stakeholders which will help establish a global FH registry to generate large-scale, robust data on the burden of FH worldwide.METHODS: The EAS FHSC will maximise the potential exploitation of currently available and future FH data (retrospective and prospective) by bringing together regional/national/international data sources with access to individuals with a clinical and/or genetic diagnosis of heterozygous or homozygous FH. A novel bespoke electronic platform and FH Data Warehouse will be developed to allow secure data sharing, validation, cleaning, pooling, harmonisation and analysis irrespective of the source or format. Standard statistical procedures will allow us to investigate cross-sectional associations, patterns of real-world practice, trends over time, and analyse risk and outcomes (e.g. cardiovascular outcomes, all-cause death), accounting for potential confounders and subgroup effects.CONCLUSIONS: The EAS FHSC represents an excellent opportunity to integrate individual efforts across the world to tackle the global burden of FH. The information garnered from the registry will help reduce gaps in knowledge, inform best practices, assist in clinical trials design, support clinical guidelines and policies development, and ultimately improve the care of FH patients.

U2 - 10.1016/j.atherosclerosissup.2016.10.001

DO - 10.1016/j.atherosclerosissup.2016.10.001

M3 - Journal article

C2 - 27939304

SN - 1567-5688

VL - 22

SP - 1

EP - 32

JO - Journal of atherosclerosis research

JF - Journal of atherosclerosis research

ER -